Methanex (NASDAQ:MEOH – Free Report) (TSE:MX) had its target price increased by Barclays from $54.00 to $57.00 in a report ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Affirm (NASDAQ:AFRM – Free Report) had its target price raised by Barclays from $75.00 to $85.00 in a report released on Monday morning,Benzinga reports. They currently have an overweight rating on ...

Victory Capital (NASDAQ:VCTR – Free Report) had its target price increased by Barclays from $70.00 to $75.00 in a research ...

Barclays (LON: BARC) cited a U.S. Department of Energy study, which projects that electricity demand from data centers could ...

Phibro Animal Health (NASDAQ:PAHC – Free Report) had its price objective raised by Barclays from $20.00 to $22.00 in a research report report published on Monday morning,Benzinga reports. The firm ...

Paylocity (NASDAQ:PCTY – Free Report) had its price objective upped by Barclays from $214.00 to $231.00 in a research report ...

O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its price objective increased by Barclays from $1,110.00 to $1,250.00 in ...

Susquehanna cut shares of NetApp (NASDAQ:NTAP – Free Report) from a positive rating to a neutral rating in a research report report published on Monday morning, MarketBeat.com reports. They currently ...

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective reduced by Guggenheim from $165.00 to $163.00 in a report published on Monday,Benzinga reports. They currently have a buy ...

Barclays downgraded Illumina Inc (NASDAQ:ILMN) to "Underweight" given growing uncertainty in China, rising competition from Roche in the clinical market, and weaker-than-expected elasticity in ...

Newell Brands (NASDAQ:NWL – Free Report) had its target price cut by Citigroup from $10.50 to $7.75 in a research note published on Monday morning,Benzinga reports. They currently have a neutral ...